With the global cord blood banking industry maturing and consolidating over the past five years, it is more important than ever to be well-educated about cord blood industry trends.
There are now fewer market players, because many small cord blood banks have either been acquired or gone out of business. However, existing cord blood banks are now better positioned to leverage their resources. With the global cord blood banking industry maturing substantially over the past few years, it has created both serious threats and novel opportunities.
Therefore, the “Complete 2015-16 Global Cord Blood Banking Industry Report“ discusses trends in cord blood industry clinical trials, scientific publications, patents, and grants. It also considers clinical trial market data supporting applications for hematopoietic stem cells (HSCs) from cord blood and mesenchymal stem cells (MSCs) from cord tissue.
Considering both traditional analytics and new social analytics (derived from Google Trends, Google Search, and top social media platforms), it is a comprehensive overview of trends impacting the cord blood banking industry today.
Cord Blood Industry Threats
Serious threats to the cord blood banking industry include new accreditation requirements that have increased the cost structure of cord blood banks, a recent decline in cord blood transplants within the U.S. and other geographical regions, low rates of turnover for stored cord blood units, expensive cord blood transplantation procedures costing from $200-300K each, difficulty with educating obstetricians about cellular therapies, and poor press coverage in many regions worldwide.
Other uncontrollable factors that could threaten the industry include: new legislation, changes in transplant reimbursement, continually evolving accreditation requirements, the potential for competitive approaches to be shown as more optimal, patent challenges for processing or transplant technologies, changes in public perception of private vs. public banking, shift in policy recommendations by influential medical organizations, and changes in government support.
Marketing pressures are also impacting the industry, with the term “cord blood” becoming one of the 20 most expensive search terms on Google, reaching more than $20 per click for global search traffic and close to $40 per click for U.S. search traffic.